Lexington Biosciences Inc. (LXGTF)

[LittleBlondie]

SUMMARY LXGTF : Lexington BioSciences (CSE: LNB) (OTCQB: LXGTF) is developing the HeartSentry, a new non-invasive diagnostic tool for accurately measuring and monitoring cardiovascular health.

• The HeartSentry measures the function of the endothelium – the critical inner lining of a person’s cardiovascular system.

• The core research and IP portfolio has been exclusively licensed to the company.

• Lexington is in final stages of releasing the product into clinical studies for FDA approval.

• The cardiovascular diagnostic market is growing fast and evolving into
personalized medicine.

• The goal is to make HeartSentry the standard of care for cardiologists, general practitioners, and ultimately patients first line evaluation of cardiovascular
health.

• We seek the participation of dedicated stakeholders and committed
partners who share our vision of the future of cardiovascular personalized
medicine.